Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2021)

Insight Molecular Diagnostics (IMDX) posted Tax Provisions of -$97000.0 for Q4 2021, up 94.59% sequentially from -$1.8 million in Q2 2021, and down 161.01% YoY from $159000.0 in Q4 2020.

Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2021) Analysis & Trends

Insight Molecular Diagnostics (IMDX) has 2 years of Tax Provisions data on file, last reported at -$97000.0 in Q4 2021.

  • Quarterly Tax Provisions fell 161.01% year-over-year to -$97000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2024 was -$97000.0 (changed N/A YoY) and the FY2022 annual result came in at -$8.1 million, up 12.9% from the prior year.
  • Tax Provisions grew to -$97000.0 in Q4 2021 per IMDX's latest filing, from -$1.8 million in the prior quarter.
  • The five-year high for Tax Provisions was $1.1 million in Q1 2020, with the low at -$7.6 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn -16.00 Mn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn 70.00 Mn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn 206.00 Mn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn 77.00 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn 300,000.00
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn 69.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn 59.00 Mn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn 23.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn 40.20 Mn
10 Insight Molecular Diagnostics 196.41 Mn 167.48 Mn 15,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2021 -97,000.00
Jun 30, 2021 -1.79 Mn
Mar 31, 2021 -7.56 Mn
Dec 31, 2020 159,000.00
Jun 30, 2020 -2.19 Mn
Mar 31, 2020 1.10 Mn